期刊文献+

沉默信息调控因子1通路介导补骨脂酚抑制脂多糖诱导的乳鼠心肌细胞炎症反应及凋亡 被引量:5

Bakuchiol ameliorates LPS-induced cardiomyocyte inflammation and apoptosis via SIRT1 pathway
下载PDF
导出
摘要 目的研究补骨脂酚(BAK)对脂多糖(LPS)诱导的SD乳鼠心肌细胞炎症反应模型的作用及其分子机制。方法SD乳鼠心肌细胞经1μM、5μM或10μM的BAK孵育4 h后,再用LPS(100 ng/ml)孵育12 h,造成炎性心肌细胞损伤。用CCK8法检测心肌细胞活力,TUNEL法检测心肌细胞凋亡水平。ELISA法检测培养基中炎性因子TNF-α和IL-1水平,Western-blot法检测SIRT1、Bax和Bcl-2的表达水平。使用沉默信息调控因子1(SIRT1)阻断剂EX527观察SIRT1信号通路在这一过程中的作用。结果 LPS处理可以诱导心肌细胞炎性因子肿瘤坏死因子-α和白介素-1释放(P<0.05 vs control组),降低心肌细胞活力并促进其凋亡。蛋白水平抑制SIRT1表达,Bcl2下调,Bax上调(P<0.05 vs control组)。1μM、5μM和10μM的BAK预孵育可浓度依赖性地抑制炎性因子释放、改善心肌细胞活力、上调SIRT1表达,提高Bcl2并降低Bax表达,抑制心肌细胞凋亡。SIRT1阻断剂EX527可显著抑制上述抗炎及抗凋亡作用。结论 BAK通过激活SIRT1信号通路,减轻LPS诱导的大鼠心肌细胞炎症反应。 Objective To investigate whether BAK exerts an effect on LPS-induced cardiomyocyte inflammation and the mechanisms involved.Methods Neonatal rat ventricular myocytes (NRVMs) were pretreated with BAK in three dose (1/5/10 μM) for 4hours and then subjected to LPS stimulation (100 ng/ml,12 hours).CCK-8 kits were used to measure cell viability.To analyze cardiomyocyte apoptosis,TUNEL assay was performed.ELISA kits were used to measure TNF-α IL-1 and the expression of SIRT1,Bcl2 and Bax were evaluated by western blotting.The specific inhibitor of SIRT1,EX527 were used to investigate roles of SIRT1 in this process.Results LPS administration could induce the release of inflammation factors (TNF-α IL-1) and LDH1 in neonatal rat ventricular myocytes (NRVMs).Lower cell viability and more apoptosis were observed.Decreased SIRT1 was observed in LPS-induced inflammation (P〈0.05,vs control group).After administration of BAK,as demonstrated by dose-independent decreases of TNF-α IL-1 and LDH1 cell viability increased while less apoptosis was observed.Western blot analysis showed an upregulation of SIRT1 and Bcl2/Bax ratio.EX527 reversed the anti-inflammatory function of BAK.Conclusion BAK pretreatment may prevent LPS induced inflammation and reduce cardiomyocyte apoptosis via SIRT1 signaling pathway in myocytes.
作者 秦志刚 徐学增 谭延振 赵达君 杨阳 易蔚 金振晓 易定华 Qin Zhi-gang Xu Xue-zeng Tan Yan-zhen Zhao Da-Jun Yang Yang Yi Wei Jin Zhen-xiao Yi Ding-hua(Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Shaan'xi Xi'an 710032, China)
出处 《中国体外循环杂志》 2017年第3期174-178,184,共6页 Chinese Journal of Extracorporeal Circulation
基金 国家自然科学基金优秀青年项目(81422004) 面上项目(81570231 81470480 81670356)
关键词 补骨脂酚 心肌炎症损伤 沉默信息调控因子1 Bakuchiol LPS-induced inflammation Silent information regulation 1
  • 相关文献

参考文献3

二级参考文献43

  • 1吴华,刘亚湘,毛向辉,蔡开灿,王武军.经皮心肺支持急救重症暴发性心肌炎[J].中国体外循环杂志,2004,2(4):220-221. 被引量:11
  • 2赵丕文,王大伟,牛建昭,王继峰,王玲巧.红花等10种中药的植物雌激素活性研究[J].中国中药杂志,2007,32(5):436-439. 被引量:107
  • 3[1]Phillips SJ, Ballentine B, Slonine D, et al. Percutaneous initiation of cardiopulmonary bypass[J]. Ann Thorac Surg,1983,36(2): 223-225.
  • 4[2]Phillips SJ, Zeff RH, Kongtahworn C, Percutaneous cardiopulmonary bypass: application and indication for use[J]. Ann Thorac Surg,1989, 47(1): 121-123.
  • 5[3]Ostrowska G. Cardiopulmonary percutaneous support. Indications and methods[J]. Pol Merkuriusz Lek, 1998,5(27): 167-172.
  • 6[4]Hata M, Shiono M, Orime Y, et al. Strategy of circulatory support with percutaneous cardiopulmonary support[J]. Artif Organs,2000,24(8): 636-639.
  • 7[5]Kurusz M, Zwischenberger JB. Percutaneous cardiopulmonary bypass for cardiac emergencies[J]. Perfusion,2002,17(4): 269-277
  • 8[6]Morishima I, Sassa H, Sone T, et al. Koyama T. A case of fulminant myocarditis rescued--by long-term percutaneous cardiopulmonary support[J]. Jpn Circ J, 1994, 58(6): 433-438.
  • 9[7]Kato S, Morimoto S, Hiramitsu S, et al. Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis[J]. Am J Cardiol, 1999,83(4): 623-625.
  • 10[8]Inoue Y, Kaneko H, Yoshizawa Y, et al. Rescue of a child with fulminant myocarditis using percutaneous cardiopulmonary support[J]. Pediatr Cardiol, 2000, 21(2): 158-160.

共引文献30

同被引文献39

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部